Aberrant fibroblast growth factor receptor (FGFR) signaling has been reported to induce EMT and stemness in prostate cancer cell lines by activating the RAS/MAPK, PI3K/AKT, and JAK/STAT pathways. Here, AKT1 is linked to prostate carcinoma.